I thought IMU wanted to partner with pharmaceutical companies to take drugs to phase 3? So clearly commercial deals can be made though they have more risk/less value than if full FDA approval has already been given.
There might be a market for all these drugs but the value is going to be compromised if something better comes along. Presumably the IMU team is aware of competition within and outside for their drugs and the impact it is likely to have on value and getting deals made.
I thought IMU wanted to partner with pharmaceutical companies to...
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
-0.001(1.85%) |
Mkt cap ! $389.5M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.4¢ | 5.2¢ | $384.2K | 7.271M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 1723946 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 905438 | 6 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |